TIS 0.00% 0.0¢ tissue therapies limited

limbo, page-57

  1. 430 Posts.
    lightbulb Created with Sketch. 7

    MJS, I know most think my criticism are brutal, extreeme and repetative, however many believe there should be a free pass on this which I don't agree. So the pendulum of comment has to be swung hard to get notice and make people think. To not be critical, make the company be aware some investors are less than happy about certain matters is wrong.

    Delaying the application was wrong from the start, and also naive. It has to make one question previous and further decisions/statements regarding product developmenmt.

    I also believe the attitude towards investors has been careless and arrogant. My polite emails are never answered, especially when asking what date the requested information was asked for and then sent. My feeling is that it wasn't sent till late June. The company should have erased that end of june time frame as soon as it knew it wasn't achievable, which I believe was in early June. It was a very important timeframe as it had been held up since November as launch time. You only have to go back through this blog to know it had consequences to people.

    If the commercialisation of this product shows to be wanting, others will see it, and a takeover will happen quickly, as better managed business will know they can create better value from the product. And we will loose the opportunity to maximise this opportunity. There are consequences.

    Full credit to the product development if its all its cracked up to be. Commercialisation is another matter.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.